CN Patent

CN104718188B — N-取代的苯甲酰胺类及其在治疗疼痛中的用途

Assigned to Xenon Pharmaceuticals Inc · Expires 2018-08-21 · 8y expired

What this patent protects

本发明提供了具有以下通式(I)的新化合物及其可药用盐、含有该化合物的组合物和使用该化合物和组合物的方法，其中变量R A 、下标n、环A、X 2 、L、下标m、X 1 、B、R 1 、R 2 、R 3 、R 4 、R 5 和R N 具有如本文所描述的含义。

USPTO Abstract

本发明提供了具有以下通式(I)的新化合物及其可药用盐、含有该化合物的组合物和使用该化合物和组合物的方法，其中变量R A 、下标n、环A、X 2 、L、下标m、X 1 、B、R 1 、R 2 、R 3 、R 4 、R 5 和R N 具有如本文所描述的含义。

Drugs covered by this patent

fosnetupitant-chloride-hydrochloride (FOSNETUPITANT CHLORIDE HYDROCHLORIDE)

Patent Metadata

Patent number: CN104718188B
Jurisdiction: CN
Classification: —
Expires: 2018-08-21
Drug substance claim: No
Drug product claim: No
Assignee: Xenon Pharmaceuticals Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.